{"id":1116,"date":"2023-09-21T15:16:05","date_gmt":"2023-09-21T15:16:05","guid":{"rendered":"https:\/\/quantadt.wpengine.com\/us\/?post_type=testimonial&#038;p=1116"},"modified":"2023-09-21T15:16:05","modified_gmt":"2023-09-21T15:16:05","slug":"john-e-milad-ceo-quanta-3","status":"publish","type":"testimonial","link":"https:\/\/quantadt.com\/us\/testimonial\/john-e-milad-ceo-quanta-3\/","content":{"rendered":"\n<p>Kidney failure is one of the costliest health conditions for the American health system. The imperative for better value in healthcare, coupled with new challenges driven by COVID-19, has amplified the need to reimagine how hemodialysis is delivered across a variety of settings. This will be a pivotal year for Quanta as we build our US presence and bring our next generation hemodialysis system to a community ripe with need.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"content-type":""},"class_list":["post-1116","testimonial","type-testimonial","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/testimonial\/1116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/testimonial"}],"about":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/types\/testimonial"}],"wp:attachment":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media?parent=1116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}